Portland biotech aims to ease side effects of common treatment
March 09, 2022 at 10:50 AM EST
The startup closed a $50 million funding round last year and has three clinical trials in the works.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|